Log In
Print
BCIQ
Print
Print this Print this
 

NuroPro test

  Manage Alerts
Collapse Summary General Information
Company Amarantus BioScience Holdings Inc.
DescriptionBlood test for early detection of neurodegenerative diseases
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationNeurology, Diagnostic
Indication DetailsDetect neurodegenerative diseases; Diagnose Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today